1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma
(
- Contribution to journal › Article
- 2022
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Development and validation of a quantitative electron microscopy score to assess acute cellular stress in the human exocrine pancreas
(
- Contribution to journal › Article
-
Mark
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
(
- Contribution to journal › Scientific review
- 2020
-
Mark
NTRK fusions in osteosarcoma are rare and non-functional events
(
- Contribution to journal › Article
-
Mark
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker
(
- Contribution to journal › Article
-
Mark
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
(
- Contribution to journal › Article